No Photo Available

Last Update


This profile was last updated on .

Is this you? Claim your profile.

Wrong David Low?

Dr. David A. Low

Professor In Department of Molecular, Cellular, and Developmental Biology

University of California , Santa Barbara

HQ Phone: (805) 893-8000

Email: l***@***.edu

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

University of California , Santa Barbara

342 Lagoon Road Mail Code 2055

Santa Barbara, California 923106-2055

United States

Company Description

The University of California, Santa Barbara (UCSB) is one of 10 universities in the University of California system, and is one of only 62 research-intensive institutions elected to membership in the prestigious Association of American Universities. The d ... more

Find other employees at this company (12,349)

Background Information

Employment History

Professor In Department of Molecular, Cellular, and Developmental Biology

UC Santa Barbara Foundation




University of Utah


American Association for the Advancement of Science

American Academy of Microbiology

Postdoctoral Fellow
Stanford University



University of California , Irvine


University of California at Irvine


cellular biochemistry

UC Irvine

bachelor's degree


UC San Diego

master's degree


San Diego State University

Web References (55 Total References)

Remedyne Management Team [cached]

David Low, Ph.D.Chief Scientific Officer and Director

Dr. Low is currently a professor in the department of Molecular, Cellular and Developmental Biology at the University of California, Santa Barbara.Previously, he served as a professor in the department of Pathology at the University of Utah and also served on editorial boards of Applied and Environmental Biology and Microbiology.Dr. Low has been honored with an NIH Career Development Award and the LaSalle Memorial Scholarship in Microbiology.He has contributed to over 53 publications in biochemistry, immunology and molecular biology and is a co-holder of the patent (pending) for Remedyne's DNA Adenine Methylase Technology.Dr. Low completed his Ph.D. at the University of California, Irvine and received his postdoctoral fellow at Stanford University.

Kenny Slaught - Congratulates UCSB for Receiving Grand Challenges Explorations Grant [cached]

David Low, a professor in UCSB's Department of Molecular, Cellular, and Developmental Biology, will pursue an innovative global health and development research project titled, "Strategy for development of enteric pathogen-specific phage. Low's research focuses on a new way to deal with serious bacterial pathogens that are becoming resistant to many once-powerful antibiotics.

Self-Perpetuating Structural States in Biology, Disease, and Genetics [cached]

David Low, UC Santa Barbara

Gordon Research Conferences - 2014 Program - Bacterial Cell Surfaces [cached]

David Low (University of California, Santa Barbara) "Mechanisms of Self/Non-Self Recognition and Generation of Toxin Diversity in CDI and Rhs Contact-Dependent Growth Inhibition Systems"

One bacterial cell can stop the growth of another on physical contact [cached]

"This has potential implications for new antibiotics," said Low.

The discovery by a team of scientists working in the laboratory of David Low, professor of biology at the University of California, Santa Barbara, is reported in the August 19 issue of the journal Science. The findings indicate that Escherichia coli, one culprit in urinary tract infections, contains genes that when turned on block the growth of other E. coli bacteria that they touch. The finding was a complete surprise to the scientists, said Low.
The discovery may eventually lead to new antimicrobial agents to halt bacterial growth which would be an entirely new system to shut bacteria down, according to the scientists. "This has potential implications for new antibiotics," said Low.
"We don't know if these 'stopped' cells are dead or alive," said Low.
Low said that one possible interpretation is that bacteria use this system to eliminate competition in the environments they grow in. "Another possibility is that the bacteria use the CDI system to shut themselves off inside a host, going into a dormant state where they may go undetected by the immune system," he said.
Thousands of women in this country have chronic urinary tract infections, noted the scientists. The disease seems to go away for awhile, then something triggers recurrence of the disease.
Work by Scott Hultrgen at Washington University has indicated that E. coli cells may hide in the walls of the bladder and urinary tract in a dormant state, explained Low.
"This research is in its infancy, but opens the door for exploration of the roles of contact-dependent growth inhibition in urinary tract infections and possibly other diseases," said Low.
"Aoki has discovered an entirely new phenomenon," explained Low, who has studied E. coli for over 20 years.
David Low can be reached at (805) 893-5597, or by e-mail at [email protected]

Similar Profiles

Other People with this Name

Other people with the name Low

James Low
DBS Bank Limited

Patrick Low
OC&C Strategy Consultants GmbH

WanYi Low
ASUS company

Mona Low
The Pioneer Companies

Michelle Low
Farringdon Group Ltd

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory